Eledon Pharmaceuticals (ELDN) - Earnings growth in current year

Official company branding of Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals' innovative approach to immune control correlates with year-over-year EPS growth rates, which this chart on GURU.Markets reflects as a current metric via the -76.80 mark. The absence of direct modern analogues protects the company from price wars. Meanwhile, the diversification of clinical development stages for small molecules significantly mitigates potential regulatory business risks.

ELDN - Eledon Pharmaceuticals Earnings growth in current year over the range 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company Eledon Pharmaceuticals, Inc. (ELDN)

Fundamental valuation:ELDN Eledon
Signature product of eledon.com

To minimize risks, capital should be allocated to assets with predictable returns, where the 12-month earnings per share growth rates reflect the annual net income dynamics per security. This indicator allows for an assessment of the business scaling efficiency of Eledon Pharmaceuticals (ELDN), taking into account the costs of environmental modernization of laboratories and the implementation of emission filtration systems.

Direct competitors

Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Earnings per share increase in current year|Earnings growth in current year SEPN (septerna.com)|Earnings growth in current year pieris.com PVLA|SVRA: Net earnings per share growth this year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Astria Corp (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene|Earnings growth in current year RAPT Therapeutics|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (kyvernatx.com)|TLSA - Net earnings per share growth this year|CABA - Earnings per share growth in current year|Ventyx Biosciences (VTYX) - Net earnings per share growth this year|Theratechnologies, Inc. (THTX) - Earnings per share growth in current year|Net earnings per share growth this year Avalo Therapeutics, Inc.|AGEN (Agenus, Inc) - Earnings growth in current year|Climb Bio, Inc. - Earnings per share trend in current year|Earnings per share growth in current year Zura Bio (ZURA)|ATYR - Earnings per share growth rate in current year|Earnings per share growth in current year Adagene ADAG|Earnings per share increase in current year IMA|STTK: Net earnings per share growth this year|Earnings per share increase in current year EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Earnings per share growth in current year|Immunic, Inc. (IMUX) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|X4 Pharmaceuticals Inc. (XFOR) - Earnings per share increase in current year|Net earnings per share growth this year Adicet ACET|Earnings growth in current year CELU (Celularity Inc)|Earnings growth in current year INmune Bio INMB|Barinthus Biotherapeutics plc - Earnings growth in current year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth this year|SAB Biotherapeutics, Inc (SABS) - Earnings per share growth in current year|Net earnings per share growth this year Akari Therapeutics plc|Earnings per share growth in current year enlivex.com|Earnings per share growth rate in current year q32bio.com QTTB|Earnings per share growth in current year GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Earnings per share increase in current year|Earnings per share growth in current year ibioinc.com IBIO|Earnings growth in current year carismatx.com CARM|XTLB - Earnings per share growth in current year|Earnings per share increase in current year BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo|Net earnings per share growth this year AIM|Earnings per share growth this year ADTX (aditxt.com)|Earnings per share growth in current year GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year HIND (Vyome Therapeutics)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year